Details of CPPsite entry with Sequence CRGDK |
| Primary information | |
|---|---|
| PEPTIDE SEQUENCE | CRGDK |
| CPPsite ID | 2098, |
| PEPTIDE NAME | CRGDK |
| CHIRALITY | L |
| LINEAR/CYCLIC | Linear |
| SOURCE | Synthetic |
| SUB CELLULAR LOCALIZATION | Lysosomes and Cytoplasm |
| N-TERMINAL MODIFICATION | Free |
| C-TERMINAL MODIFICATION | Free |
| UPTAKE EFFICIENCY | Neuropilin-1 mediated |
| INVITRO/INVIVO | In vitro and in vivo |
| CELL LINE | human metastatic breast cancer cell line MDA-MB- 231, the aggressive human metastatic prostate cancer cell line PC3 |
| In VIVO MODEL | Nude mice bearing MDA-MB-231 tumors |
| CARGO | Small molecule drug (Doxorubicin), DSPE- PEG2000 |
| PMID | 23634882 |
| PATENT | Unknown |
| Tertiary Structure (Technique) | 2098 (PEPstrMOD), |